Abstract
Optic atrophy 1 ( OPA1 ) mutations cause dominant optic atrophy (DOA) with retinal ganglion cell (RGC) and optic nerve degeneration. The mechanism for the selective degeneration of RGCs in DOA remains elusive. To address the mechanism, we reduced OPA1 protein expression in cell lines and RGCs by RNA interference. OPA1 loss results in mitochondrial fragmentation, deficiency in oxidative phosphorylation, decreased ATP levels, decreased mitochondrial Ca 2+ retention capacity, reduced mtDNA copy numbers, and sensitization to apoptotic insults. We demonstrate profound cristae depletion and loss of crista junctions in OPA1 knockdown cells, whereas the remaining crista junctions preserve their normal size. OPA1-depleted cells exhibit decreased agonist-evoked mitochondrial Ca 2+ transients and corresponding reduction of NAD + to NADH, but the impairment in NADH oxidation leads to an overall more reduced mitochondrial NADH pool. Although in our model OPA1 loss in RGCs has no apparent impact on mitochondrial morphology, it decreases buffering of cytosolic Ca 2+ and sensitizes RGCs to excitotoxic injury. Exposure to glutamate triggers delayed calcium deregulation (DCD), often in a reversible manner, indicating partial resistance of RGCs to this injury. However, when OPA1 is depleted, DCD becomes irreversible. Thus, our data show that whereas OPA1 is required for mitochondrial fusion, maintenance of crista morphology and oxidative phosphorylation, loss of OPA1 also results in defective Ca 2+ homeostasis.
Similar content being viewed by others
Main
Mutations in optic atrophy 1 (OPA1), a dynamin-related large GTPase with mitochondrial fusion function, cause dominant optic atrophy (DOA), the most common hereditary form of optic neuropathy.1, 2 Progressive degeneration of retinal ganglion cells (RGCs) and the optic nerve, the hallmarks of DOA, are associated with several functional and structural alterations of mitochondria (reviewed in Lenaers et al.3). Whereas the OPA1 mutation in DOA patients is present from birth in all cells, it remains unknown why only certain cell types, such as RGCs, degenerate4, 5, 6, 7, 8 and what are the mechanisms leading to their loss.
In addition to its role in mitochondrial fusion, OPA1 governs crista architecture. OPA1 is anchored in the mitochondrial inner membrane and faces the intermembrane space.9, 10 Electron microscopy (EM) analyses indicate that OPA1 loss causes abnormal mitochondrial ultrastructure with cristae disorganization.9, 10, 11 Interaction of OPA1 with membranes can induce a structural remodeling into tubules,12 a feature characteristic of crista junctions,13, 14, 15 supporting the proposal that OPA1 is a key component of these junctions.16, 17, 18 Because crista junctions are normally uniform, a change in their size may indicate alteration in mitochondrial functional status. Yet, disagreements have arisen concerning crista junction remodeling in apoptosis.17, 18, 19, 20, 21
Emerging evidence suggests that abnormal Ca2+ homeostasis contributes to the pathogenesis in DOA.22, 23 Ca2+ enters mitochondria via the Ca2+ uniporter where it stimulates NADH and ATP production via activation of NADH-producing dehydrogenases including pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase, and NAD-linked isocitrate dehydrogenase.24 During neurotransmission, ionotropic glutamate receptors, including the N-methyl-D-aspartate (NMDA) receptor, open and cytoplasmic Ca2+ accumulates in neurons and regulates downstream enzymes and signaling pathways.25 However, if excessive glutamate is released into the extracellular space, for example, during stroke, epilepsy, or neuronal injury, neurons suffer excitotoxic damage. In cell culture models, a phenomenon known as delayed Ca2+ deregulation (DCD) occurs during acute glutamate exposure.26, 27 DCD is thought to be a consequence of mitochondrial Ca2+ overload-mediated injury,28 and in most paradigms leads to neuronal cell death.29, 30 Remarkably, RGCs are known to be resistant to excitotoxicity in contrast to hippocampal neurons.31
To investigate the mechanism of RGC degeneration in DOA, OPA1 expression in cell lines and primary RGCs was decreased by RNAi, and ultrastructure, bioenergetics, and Ca2+ homeostasis of control and RNAi cells were compared. We demonstrate that in RGCs, decreased mitochondrial Ca2+ buffering and DCD occur in the absence of significant changes in mitochondrial morphology, suggesting a functional role of OPA1 in Ca2+ signaling.
Results
OPA1 loss results in mitochondrial fission and sensitization to apoptosis
To explore the effects of OPA1 loss on cellular function we transfected cells with OPA1 small interfering RNA (siRNA). Because RGCs constitute only 1% of all cells in the retina and the yields are low after purification, we were forced to use cell lines (HeLa cells) for some experiments. Although control HeLa cells exhibited a typical fused mitochondrial network, ∼80% of OPA1 siRNA cells showed dramatic mitochondrial fragmentation (Figure 1a). Effective OPA1 knockdown was confirmed by immunoblotting (Supplementary Figure 1).
Previous studies have reported that cells lacking OPA1 spontaneously release cytochrome c from mitochondria and undergo cell death.9, 32 However, subcellular fractionation with immunoblotting (Figure 1b) and confocal microscopy of OPA1 siRNA cells (Figures 1c and d) demonstrated that OPA1 knockdown did not result in spontaneous cytochrome c release from mitochondria. Measurements of cell death by three independent methods (Figures 1e–g and Supplementary Figure 2) did not reveal greater than baseline cell death in OPA1 siRNA cells. However, in agreement with an earlier study,32 OPA1 siRNA cells died faster when challenged with staurosporine (STS), an apoptosis inducer, and exhibited a significantly higher caspase activity after STS treatment than STS-treated control cells (Figures 1e and f). Taken together, these data indicate that OPA1 loss per se does not cause cytochrome c release from mitochondria or cell death; instead, it conveys an increased susceptibility to apoptosis.
OPA1 loss leads to cristae depletion
Conventional 2D EM analyses demonstrate that OPA1 loss causes abnormal mitochondrial ultrastructure.9, 10, 11 However, a detailed 3D picture and quantitative analysis of the mitochondrial ultrastructure in intact, mammalian OPA1-deficient cells are lacking. Only 3D reconstructions of isolated mitochondria from OPA1-null cells were published previously.17 To gain better insights into the mitochondrial ultrastructure in OPA1 knockdown cells, we performed EM tomography and a high-resolution mitochondrial quantitative analysis. Through tomographic reconstructions from scrambled siRNA-transfected cells, 2-nm thick slices show elongated mitochondria and an intact outer mitochondrial membrane (OMM; Figures 2A and B; Supplementary Movie File 1). The tomographic view of mitochondria in OPA1 siRNA cells was dramatically different from controls, not surprisingly showing many more round and small mitochondria. Figures 2A and Bc–f show a triplet of mitochondria from OPA1 siRNA cells whose OMMs are in close contact, suggesting recent fission before fixation. As with the control mitochondria, no signs of OMM breaks or matrix swelling were observed, consistent with our observation that cytochrome c remains localized within mitochondria and spontaneous cell death does not occur. Mitochondria of OPA1 siRNA cells displayed fewer and smaller cristae (Figures 2Bc–f), with some mitochondria even devoid of cristae (Figures 2Bd and f and Supplementary Movie File 2). A few mitochondria had cristae oriented parallel to the long axis of the organelle, unusual for HeLa cells.
Additionally, in tomographic volumes, we quantified mitochondrial numbers per cubic micron and mitochondrial volume relative to cellular volume. Although there was no difference in the total mitochondrial volume, mitochondrial number increased twofold in OPA1 siRNA-transfected cells (Figures 2Ca and b). These results confirm that OPA1 loss promotes mitochondrial fission rather than a decrease in mitochondrial density. We also measured cristae surface area compared with that of the OMM surface area and evaluated cristae surface area relative to cell volume (Figures 2Cc and d). The total cristae membrane surface area of OPA1 siRNA-transfected cells was 25% less than that of controls (Figures 2Cc and d).
OPA1 loss leads to mitochondrial structural heterogeneity, but not widening of crista junctions
Because of the report of heterogeneity in mitochondrial membrane potential (Δψm) after OPA1 loss,33 we investigated possible accompanying structural heterogeneity. Using conventional EM, we found that ∼10% of mitochondria were considerably more condensed than the majority (Figures 3a–e). To clarify whether crista junction changes occurred in our OPA1 siRNA samples, we measured junctional sizes in tomographic volumes. In agreement with the previous report,17 we found that the junctional size remains essentially unaltered with loss of OPA1 (Figures 3f–h; 10.0±0.4 nm for control and 8.9±0.5 nm for OPA1 siRNA crista junctions; mean±S.E.M.). However, the number of junctions was significantly reduced in OPA1 siRNA mitochondria (Figure 3h; 54±4 CJ/S.A. for control and 21±6 CJ/S.A. for OPA1 siRNA; mean±S.E.M.; P<.001). Loss of crista junctions is consistent with cristae depletion (Figure 2); this phenomenon was also reported in a previous study using a TOM19-removal mechanism for cristae depletion.34 Collectively our findings indicate that OPA1 loss results in cristae depletion without dilation of their junctions.
OPA1 loss results in bioenergetic defects, mtDNA loss, and impaired mitochondrial Ca2+ buffering
Because mitochondrial cristae are abnormal in OPA1 siRNA cells, we investigated the impact of these abnormalities on bioenergetics. Respiratory changes induced by OPA1 knockdown were evaluated in digitonin-permeabilized and intact cells. To measure respiration in digitonin-permeabilized cells, mitochondria were supplemented with Complex I-linked substrates, glutamate and malate. The rates of ADP-induced (state 3) and maximal (carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP)-induced or state 3u) respiration were reduced by ∼20% in OPA1 siRNA cells compared with controls (Figure 4A and Table 1). Comparable inhibition of respiration was observed in intact OPA1 siRNA cells (Table 1). Note that the oligomycin-inhibited (state 4o) respiration, an indicator of proton leak through the inner mitochondrial membrane, remained unaltered in digitonin-permeabilized and intact OPA1 siRNA cells (Figure 4A). Thus, OPA1 loss does not induce proton leak and mitochondrial uncoupling, but rather causes partial respiratory inhibition.
The maximal rate of respiration may be limited by the transport of substrates and/or activity of the tricarboxylic acid cycle, in addition to the activity of the electron transport chain. To directly test Complex I activity coupled with the activity of downstream complexes, we measured rotenone-sensitive NADH-dependent respiration in alamethicin-permeabilized mitochondria. Figure 4B illustrates that the activity of electron transport chain (Complexes I–III–IV) was reduced by 39±4% (n=4) in OPA1 siRNA cells. Consistent with the reduced respiratory capacity, OPA1 siRNA cells displayed lower ATP levels (Figure 4C).
Next, we determined the mitochondrial DNA copy number by quantitative PCR. The mitochondrial DNA (mtDNA) to nuclear DNA (nDNA) ratio was significantly decreased in OPA1 siRNA cells (Figure 4D). Thus, mitochondrial crista depletion and the mtDNA copy number decrease may be the causes of partial respiratory inhibition resulting from OPA1 loss.
To dissect further the downstream mechanism of mitochondrial dysfunction in OPA1 siRNA cells, we assessed mitochondrial Ca2+ retention capacity using digitonin-permeabilized cells. Extramitochondrial Ca2+ concentration (Figure 4Ea) was measured simultaneously with measurements of Δψm (Figure 4Eb) and mitochondrial swelling (Figure 4Ec) in a multiparameter chamber. Control and OPA1 knockdown cells were repetitively challenged with small Ca2+ pulses. At baseline, OPA1 siRNA cells exhibited a Δψm similar to scrambled siRNA cells (Figure 4Eb). Accordingly, the initial rates of Ca2+ uptake were similar. Repeated Ca2+ additions caused a gradual decline in Δψm (Figure 4Eb) followed by abrupt depolarization, release of accumulated Ca2+ (Figure 4Ea), and mitochondrial swelling (Figure 4Ec), all indications of the mitochondrial permeability transition (MPT). Although Ca2+-induced MPT occurred in both control and OPA1 siRNA cells, the threshold concentration of Ca2+ needed to trigger mitochondrial Ca2+ release was significantly lower in OPA1 siRNA cells (Figure 4E). An ∼25% decrease in Ca2+ retention capacity was observed (Figure 4F).
OPA1 loss alters histamine-induced Ca2+ transients in intact HeLa cells
Because mitochondrial Ca2+ retention capacity was reduced in digitonin-permeabilized OPA1 siRNA cells, we tested Ca2+ homeostasis in situ using live cell and fluorescence time-lapse microscopy. Mitochondrial and cytosolic Ca2+ concentrations ([Ca2+]m and [Ca2+]c, respectively) were assessed with the Ca2+-sensitive fluorescent probe Rhod-2-AM using high-pass filtering of recorded fluorescence images.35
To elicit intracellular Ca2+ loads, cells were repeatedly challenged with short pulses of histamine, which induces inositol 1,4,5-triphosphate (InsP3)-mediated release of Ca2+ from the endoplasmic reticulum (ER). We first assessed [Ca2+]m in control and OPA1 siRNA cells. The amplitude of the [Ca2+]m transient caused by the first histamine pulse was significantly decreased in OPA1 siRNA cells compared with controls (Figures 5Aa and b). However, [Ca2+]m transients in response to all subsequent histamine stimuli were not significantly different in either amplitude or decay kinetics between both cells (Figures 5Ab and c). In contrast, histamine-triggered [Ca2+]c transients were significantly larger in OPA1 siRNA cells than in controls. This difference was also more pronounced for the first histamine pulse (Figures 5Ba and b). Additionally, the decay rate of [Ca2+]c transients was significantly higher in OPA1 siRNA cells than in controls (Figure 5Bb and c). In summary, these data support that OPA1 siRNA cells exhibit an impaired mitochondrial Ca2+ uptake and reduced buffering of cytosolic Ca2+ (Figure 4).
OPA1 loss leads to augmented reduction of the NAD(H) pool
Ca2+ activates NADH-producing dehydrogenases in the mitochondrial matrix, thereby increasing the NADH/NAD+ ratio and rate of ATP synthesis.24 NADH and NADPH exhibit indistinguishable autofluorescence, but under our experimental conditions, changes in NAD(P)H autofluorescence intensity are expected to reflect changes in the reduction state of the mitochondrial NAD(H) pool. This is because the pool size of NADP(H) is a fraction of the NAD(H) pool size, and is almost completely reduced under physiological conditions. To evaluate the Ca2+-dependent bioenergetic status in situ, we measured the NAD(P)H autofluorescence in OPA1 siRNA cells. [Ca2+] transients were evoked by exposure to repetitive histamine pulses. Each histamine application triggered a transient increase in fluorescence reflecting increased reduction of NAD+ to NADH (Figure 6Aa). Consistent with the [Ca2+]m transients shown in Figure 5, the relative peak amplitude triggered by the first application of histamine was diminished in OPA1 siRNA compared with control cells (Figure 6B). The decay time of NAD(P)H signals was shorter (Figure 6C) in OPA1 siRNA cells than in controls, which is consistent with the lower Ca2+ uptake capacity (Figures 5Aa and b). To measure the NADH/NAD+ ratio after a series of histamine stimuli, autofluorescence was calibrated by first oxidizing mitochondrial NADH to NAD+ by uncoupling respiration using FCCP. Following FCCP treatment, Complex I was inhibited by rotenone and the substrate β-hydroxy-butyrate was added allowing maximal reduction of NAD+ to NADH (Figure 6A). In control cells, the reduction level of NAD(H) pool returned to baseline following the histamine series (Figure 6D). In contrast, OPA1 siRNA cells exhibited a higher NADH/NAD+ ratio (Figure 6D). An accumulation of NADH after a histamine-evoked [Ca2+] rise in OPA1 siRNA cells is consistent with a defective respiratory capacity, and this outweighs the diminished NADH production caused by decreased Ca2+ uptake.
OPA1 loss in RGCs has no impact on mitochondrial morphology, but triggers glutamate-induced DCD
To test the effects of OPA1 loss on Ca2+ homeostasis in a pathophysiological setting relevant to optic neuropathies, we purified RGCs by immunopanning.36 Because RGC transfection efficiency was low, we labeled the siRNA with fluorescein (FAM) and determined the [Ca2+]c only of FAM-positive RGCs. Scrambled and OPA1 siRNA-transfected cells were stained similarly with MitoTracker Red (Figure 7 and Supplementary Figure 3) that indicated no substantial mitochondrial depolarization (as was also observed in HeLa cells; Figures 1A and 4E). In contrast to HeLa cells, scrambled and OPA1 siRNA-transfected RGCs exhibited similar, short mitochondria (Figure 7a). Neither mitochondrial length nor the longitudinal fraction of RGC processes occupied by mitochondria was significantly affected by OPA1 knockdown (Figure 7a and Supplementary Figure 3). To test whether OPA1 loss in RGCs has an impact on Ca2+ homeostasis, we measured [Ca2+]c using a low-affinity (Kd=2.9 μM) fluorescent Ca2+ dye, Fura-FF, which is a sensitive indicator of both physiological and pathological Ca2+ levels.
We employed two experimental paradigms to evoke Ca2+ overload in RGCs. In the first paradigm, repetitive pulses of high extracellular [K+] were used to induce plasma membrane depolarization and Ca2+ entry into the cytoplasm via voltage-dependent Ca2+ channels. The resulting cytoplasmic [Ca2+] transients were increased in OPA1 siRNA cells compared with scrambled siRNA controls, especially after repetitive stimulations; this difference was observed in a subset of OPA1 siRNA-transfected RGCs (5 out of 22; Figure 7b) but never in control RGCs. Because Ca2+ extrusion rates depend on the actual [Ca2+]c, we evaluated recovery of [Ca2+]c after washout of the high [K+] medium by measuring the decay rate uniformly when [Ca2+]c was ∼0.75 μM. The recovery after the peak was initially faster in OPA1 siRNA-transfected RGCs compared with controls (see higher extrusion rates in Figure 7b). The faster drop of [Ca2+]c after washout of high [K+] medium is consistent with decreased buffering of intracellular Ca2+. This could be because of decreased mitochondrial Ca2+ uptake, or decreased release of mitochondrially accumulated Ca2+ during the recovery phase of the [Ca2+]c transient. The Ca2+ extrusion slowed significantly after the third challenge in OPA1 RNAi, but not in control RGCs, indicating a progressive, stimulation-evoked deterioration of Ca2+ homeostasis.
In the second paradigm, sustained levels of glutamate were applied to induce Ca2+ entry via glutamate receptors. This challenge caused an immediate small transient increase of [Ca2+]c, followed by a plateau and a secondary high-magnitude [Ca2+]c rise known as DCD (Figure 7c). A significant proportion of control RGCs (6 out of 18) exhibited spontaneous reversibility of DCD, whereas in all OPA1 siRNA-transfected cells the secondary rise of [Ca2+]c was sustained and irreversible for the duration of the recording (Figure 7c). Thus, OPA1 knockdown in RGCs conferred increased sensitivity to glutamate-mediated excitotoxicity, which may provide a mechanistic explanation for their degeneration in DOA.
Discussion
OPA1 is a key mediator of mitochondrial fusion, but it is currently unclear whether defects in OPA1-mediated fusion function are solely responsible for RGC degeneration in DOA.8 Whereas HeLa cells exhibit a fused mitochondrial network that fragments into multiple round mitochondria after OPA1 loss, we report here that RGCs have much shorter mitochondria at baseline and undergo no significant change in size and shape upon OPA1 depletion. Previous studies reported mitochondrial fragmentation in OPA1 knockdown RGCs.23, 37 However, morphological changes become apparent at longer post-transfection times (1 to 2 weeks), but not at 3 days after transfection.37 Morphological changes coincided with induction of apoptosis and membrane depolarization.23 All our experiments were performed no later than 3 days after transfection. Notably, despite a lack of mitochondrial shape transformation (Figure 7 and Supplementary Figure 3), we observed a significant change in Ca2+ handling. Thus, we propose that in RGCs, impaired Ca2+ homeostasis and DCD represent an early consequence of OPA1 loss, whereas other defects associated with fusion deficiency are possibly secondary or delayed effects.
Bioenergetic defects
The trigger for RGC loss in DOA likely has several components, not least of which is a bioenergetic crisis, and may also involve altered mitochondrial network dynamics, defective mtDNA maintenance, and disrupted axonal transport.8 We found partial inhibition of respiration and decreased enzyme activity of electron transport chain complexes, but Δψm remained sufficiently high to support energy-dependent Ca2+ uptake (Figure 4). In contrast, loss of mitochondrial fusion resulted in almost complete inhibition of respiration in mouse embryonic fibroblasts,33 highlighting the variability of findings using different cellular models.
Because respiration inhibition quantitatively correlates with crista surface area reduction (25%; Figure 2), the partial loss of cristae observed here may be responsible for the bioenergetic deficiency seen in OPA1 siRNA cells and the moderate ATP decrease observed. Respiratory inhibition is consistent with observed excessive reduction of pyridine nucleotides (Figure 6), and this effect outweighs the decreased activation of dehydrogenases by the reduced Ca2+ transients. Postexercise phosphocreatine resynthesis, a measure of mitochondrial ATP generation, is delayed in patients with OPA1 mutations,38 lending further support for OPA1 influencing bioenergetics. Reduced enzymatic activity of the respiratory chain reported here is also consistent with recent finding of Complex IV deficiency in OPA1-null pancreatic β-cells.39 However, in this model, cells lacking OPA1 maintained normal copy numbers of mtDNA,39 whereas we observed mtDNA loss (Figure 4). Our data are in line with the observation that mtDNA content is lower in DOA patients.31
Ultrastructure
Several studies have demonstrated that loss of OPA1 (or its yeast ortholog Mgm1) leads to aberrant mitochondrial ultrastructure.17, 40, 41, 42, 43, 44, 45 We observed a number of structural abnormalities consisting of rounded mitochondria with smaller and fewer cristae (not unlike what Amutha et al.40 reported for Mgm1 deletion mutants) and a small fraction with condensed matrix or having cristae oriented parallel to the long axis of the organelles. At variance from an earlier study6 showing a wide range of abnormal membrane structures in OPA1 siRNA mitochondria, including curved or ring-shaped cristae, unusual cristae shapes were not observed in our model (Figure 2). The variability of reported ultrastructural changes might be due to the different time points of knockdown.
We found that partial cristae depletion is associated with reduction in the number of cristae junction. Crista junction geometry has been proposed to control molecular diffusion inside mitochondria46, 47 as well as the release of cytochrome c in apoptosis.18, 20 However, in contrast to observations in pancreatic β-cells of OPA1 KO mice,39 we did not observed dilation of crista junctions. It should be remarked that the crista junction dilation found in the pancreatic β-cells of OPA1 KO mice could be due to the increased matrix condensation observed in the study.39
Impaired mitochondrial Ca2+ handling
The clinical manifestation of OPA1 mutations is often highly variable between siblings.48 Experimental knockdown of OPA1 performed by different tools and laboratories resulted in highly variable phenotypes (see above). Ca2+ handling is not an exception from this. Here we report diminished agonist-evoked mitochondrial Ca2+ signaling consistent with attenuation of activation of matrix dehydrogenases in OPA1 knockdown cells. In contrast, Fulop et al.22 reported increased histamine-evoked mitochondrial Ca2+ transients in OPA1 knockdown cells, despite reduced Δψm, and a hastened kinetics of Ca2+ uptake in the absence of Δψm. We believe that this discrepancy can be explained by mitochondrial swelling, as they reported a high level of circularity of OPA1 knockdown mitochondria, an indicator of swelling. Mitochondrial Ca2+-fluxes may be controlled by crista junction geometry.46, 47 Dilation of crista junctions may occur by mechanical forces during overt matrix condensation,39 or mitochondrial swelling. When mitochondria swell, crista unfolding might lead to breakdown of the diffusion barrier and increased mitochondrial Ca2+ uptake. In our study, OPA1 knockdown in HeLa cells did not lead to swelling and we observed only small number of condensed mitochondria (Figure 3). The impact of crista and matrix remodeling on mitochondrial Ca2+ transport warrants further investigation.
Dayanithi et al.23 reported CCCP-triggered increase in intracellular Ca2+ levels after high [K+] stimulation in OPA1 RNAi RGCs. However, in this study extracellular Ca2+ was not removed from the medium, and therefore it is likely that the observed elevation of [Ca2+]c reflects Ca2+ entry from the extracellular space through voltage-dependent channels upon deenergization by CCCP rather than mitochondrial Ca2+ release.
Our data in permeabilized cells clearly demonstrate that OPA1 knockdown reduces mitochondrial Ca2+ retention capacity (Figure 4E) and are consistent with impaired Ca2+ buffering capacity observed in situ (Figure 5). Interestingly, a similar reduction in Ca2+ retention capacity was observed in dynamin-related protein 1 (Drp1)- and Fis1-expressing cells.49 In contrast to the active, electrophoretic Ca2+ uptake addressed in our experiments, OPA1 knockdown resulted in increased rates of passive Ca2+entry into mitochondria after depolarizing and swelling mitochondria in permeabilized HeLa cells.22
Impaired Ca2+ homeostasis and neurodegeneration
Excessive glutamate exposure evokes irreversible, high elevation of [Ca2+]c and the inability of neurons to return to normal Ca2+ homeostasis, ultimately resulting in their demise.25, 50 We report here that glutamate exposure results in irreversible DCD in OPA1 siRNA RGCs, whereas a significant fraction of control RGCs recovered and exhibited reversible DCD, indicating some level of resistance to excitotoxic damage, as was observed earlier.31 Interestingly, the NMDA receptor inhibitor memantine is able to protect RGCs in glaucomatous retinas and prevent release of OPA1 from mitochondria.51 Using cerebellar granule neurons, Jahani-Asl et al.52 showed that NMDA receptor overactivation triggers downstream Calpain activation, loss of OPA1 oligomers, deformation of crista junctions, and disruption of the respiratory chain complexes. Importantly, calpain activation is secondary to DCD.30 Therefore, loss of OPA1 might exert its deleterious effects under excitotoxic conditions by downstream activation of the cell death mediator Ca2+-dependent calpain.
DCD is controlled by two factors: initial mitochondrial Ca2+ load upon glutamate exposure53 and bioenergetic capacity of mitochondria.54 Based on our data, mitochondrial Ca2+ load is likely to be reduced in OPA1-deficient RGCs, and therefore the aggravation of DCD that was observed is possibly due to the decreased respiratory capacity. Along this line, DOA patients with higher respiratory complex activities have been reported to maintain visual acuity for a longer period of time,48 again suggesting that the bioenergetic compromise may be at the root of RGC damage. Because RGC mitochondria do not show any abnormalities in protein expression, the focus should turn to RGC idiosyncrasies in terms of mitochondrial energy metabolism and environmental stress factors.3 Our work suggests that inhibitors of excitotoxic injuries should be considered for therapeutic intervention in DOA.
Materials and Methods
Unless indicated otherwise, chemicals were of analytical or molecular biology grade and purchased from Sigma-Aldrich (St. Louis, MO, USA) or Thermo-Fisher Scientific (Waltham, MA, USA).
Cell culture
HeLa cells were purchased from American Tissue Culture Company (ATCC; Manassas, VA, USA) and grown in Dulbecco’s modified Eagle’s medium (DMEM; HyClone-Thermo-Fisher, Logan, UT, USA) containing 4.5 g/l glucose, 2 mM L-glutamine, 10% fetal bovine serum (FBS) (Tissue Culture Biologicals, Los Alamitos, CA, USA), containing 100 units/ml penicillin and 1000 μg/ml streptomycin (Invitrogen, Carlsbad, CA, USA). RGCs were isolated from postnatal rats by immunopanning36 and used at 7 days in vitro.
RNA interference
Scrambled I duplex (control) and OPA1 siRNA, the latter corresponding to nucleotides 1810–1833 of the OPA1 open reading frame (GenBank accession number AB011139) were from Dharmacon (Lafayette, CO, USA). SiRNA (100–200 nM) was transfected into HeLa or RGCs with Oligofectamine (Invitrogen). To verify siRNA transfer in RGCs, siRNA was labeled with FAM (Ambion, Austin, TX, USA). Experiments were performed on day 3 after transfection.
Subcellular fractionation and immunoblotting
Subcellular fractionation and immunoblotting were done as described previously.55 The primary antibody for cytochrome c was mouse monoclonal anti-cytochrome c (1 : 1000; clone 7H8.2.84; BD Biosciences Pharmingen, Franklin Lakes, NJ, USA). The OPA1 antibody (1 : 1000) was a gift from Dr. Kubo. Blots were probed with secondary HRP-conjugated anti-mouse antibody (1 : 2000; Amersham Biosciences, Piscataway, NJ, USA) for 2 h and immunocomplexes were visualized using a chemiluminescence detection kit (ECL) (Amersham Biosciences).
Fluorescence microscopy
HeLa cells were grown on 35 mm MatTek glass bottom dishes and mitochondria were labeled with 100 nM MitoTracker Red CMXRos (Molecular Probes, Eugene, OR, USA) for 20 min in culture medium. Cells were fixed with 0.5% glutaraldehyde (Ted Pella, Redding, CA, USA) in ice-cold PBS (HyClone-Thermo-Fisher) for 30 min and autofluorescence was quenched by 1% sodium borohydrite (Sigma-Aldrich) for 30 min at room temperature. Nuclei were stained with Hoechst 33342 (0.1 μg/ml; Molecular Probes). The 3D images were acquired using a Zeiss Axiovert 100M fluorescence microscope (Oberkochen, Germany) equipped with a Sensicam CCD camera controlled by Slidebook software (Intelligent Imaging Innovation, Denver, CO, USA). The z-series were deconvolved using the Slidebook constrained iterative algorithm and volumes were surface-rendered using Volocity 2 (Improvision, Coventry, UK).
Electron microscopy
HeLa cells were fixed as described.42 Roughly 80-nm thick sections were cut with a Reichert (Cambridge, England, UK) ultramicrotome and poststained 10 min in uranyl acetate and 2 min in Sato lead. Sections were examined using a JEOL (Peabody, MA, USA) 1200FX electron microscope operated at 80 kV. Images were recorded on film at 6000 magnification. The negatives were digitized at 1200 d.p.i. using a Nikon (Melville, NY, USA) CoolScan system, giving an image size of 2689 × 4006 pixel array and a pixel resolution of 4.2 nm.
EM tomography
Sections from in situ embedded monolayers of scrambled or OPA1 siRNA-transfected HeLa cells were cut at a thickness of 400–500 nm. EM tomography was performed as described.56 Measurements of structural features were made within segmented volumes by the programs Synuarea and Synuvolume (National Center for Microscopy and Imaging Research, San Diego, CA, USA). Numbers of mitochondria were counted in the volume and normalized by dividing by the cytoplasmic volume reconstructed.
Q-PCR
To quantify mtDNA, real-time PCR was performed as described57 using a Mx3000P real time PCR system (Stratagene, La Jolla, CA, USA) and SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). Total cellular DNA was purified with a PUREGENE Cell & Tissue kit (Gentra Systems, Minneapolis, MN, USA) 3 days after siRNA transfection. Serially diluted total cellular DNA from untransfected cells was used as a template for two standard DNA curves, one for amplification with nDNA primers and the second one with mtDNA primers. The relative quantity of amplified DNA was determined from respective standard curves for each sample, starting with 10 ng for nDNA and 0.1 ng for mtDNA and the mtDNA/nDNA ratio was calculated.
ATP measurements and cell viability
HeLa cells were plated on black 96-well plates (Costar, Corning, Corning, NY, USA). ATP levels were determined using a CellTiter-Glo luminescence assay kit (Promega, Madison, WI, USA). Luminescence was measured in a PolarStar plate reader (BMG, Berlin, Germany). Each data set was collected from replicate wells (n=6).
For cell viability measurements, cells were loaded with 2 μM Calcein-AM (Molecular Probes) in PBS. Generation of fluorescent Calcein was followed for 20 min at 490 nm excitation and 540 nm emission using a PolarStar plate reader. Cell viability of scrambled or OPA1 siRNA-transfected cells was expressed as the percentage of the rate of Calcein-AM hydrolysis measured from untransfected control cells (defined as 100%). Each data set was collected from replicate wells (n=6–8). Caspase activity was measured using the fluorogenic substrate z-DEVD-AMC (Molecular Probes). Apoptotic cell death was measured by Annexin-V-FITC staining as described previously.42
Cytochrome c immunocytochemistry and confocal microscopy
HeLa cells were grown on MatTek dishes and fixed with 3.7% formaldehyde in KCl-based PIPES-KOH, pH 7.2, buffer containing 5% sucrose, for 15 min at 37°C and permeabilized with 1% Triton in PBS for 20 min at 37°C. Non-specific binding was blocked in 2% BSA, 0.05% Tween-20, and 0.1% NaN3 for 40 min at 37°C. Samples were incubated with anti-cytochrome c antibodies in blocking solution (1 : 200, subclone 6H2B4, BD PharMingen, San Diego, CA, USA) overnight at 4°C. Samples were incubated with secondary Alexa488-conjugated antibodies (1 : 200, Molecular Probes) for 2 h at room temperature. Confocal imaging was carried out using an Olympus (Tokyo, Japan) Fluoview-1000 laser scanning confocal microscope. Image stacks of 800 × 800 pixels, 20 planes (0.09 × 0.09 × 0.5 mm3 voxel size) were recorded and projected over maximum intensity. For excitation of Hoechst 33342, Alexa-488, and MitoTracker Red, the 405, 488, and 543 nm laser lines of a diode, an Ar-ion, and a He-Ne laser, respectively, were used. Emission was detected through a DM405/488/543 dichromic mirror and the spectral detector of the microscope at 420–480, 500–530, and >560 nm, respectively.
Respiration measurements
Oxygen consumption was measured using a Clark-type electrode (Oxygraph, Hansatech Instruments, King’s Lynn, UK). HeLa cells were trypsinized, centrifuged at 500 × g, and resuspended in the culture medium. For measurements in intact cells, 8 × 106 cells were pelleted at 200 × g, 2 min and resuspended in 1 ml DMEM. After recording basal respiration for 2 to 3 min, oligomycin (1.25 μg/ml) was added followed by sequential additions of FCCP (100 nM). Respiration rates were normalized for equal numbers of live cells, evaluated by Trypan Blue exclusion.
For measurements in permeabilized cells, 8 × 106 cells were resuspended in 1 ml buffer containing 250 mM sucrose, 10 mM HEPES/KOH, pH 7.4, 2 mM KH2PO4, centrifuged at 200 × g, 2min, and resuspended in 1 ml of respiration buffer containing 125 mM KCl, 20 mM HEPES/KOH, pH 7.4, 2 mM KH2PO4, and 1 mM MgCl2. Then, 5 mM glutamate and 5 mM malate were added as respiratory substrates. The plasma membrane was permeabilized by addition of titrated amounts of digitonin (0.012%). ADP (200 μM), oligomycin (1.25 μg/ml), and FCCP (200 nM) were added, as noted.
Measurements of mitochondrial Ca2+ retention capacity, Δψm, and mitochondrial swelling
A custom-made chamber was used to simultaneously measure [Ca2+], Δψm, and optical density at 660 nm as described previously.58 To measure the Ca2+ retention capacity, 8 × 106 siRNA-transfected cells were permeabilized with digitonin (0.012%) in 1 ml of sucrose-based buffer and pelleted at 200 × g. Cells were resuspended in the respiration buffer plus 2 μM tetraphenylphosphonium (TPP+) and without MgCl2 and pulsed with successive Ca2+ (50 μM) additions. Ca2+ retention capacity was defined as the amount of Ca2+ required to induce Δψm loss and Ca2+ release.
Measurements of Complex I–III–IV enzyme activity
An assay of mitochondrial enzyme activity using a pore-forming peptide, alamethicin, has been described.59 Briefly, 8 × 106 cells were permeabilized with 0.012% digitonin and mitochondria were permeabilized with 30 μg/ml alamethicin in respiration buffer (see above) containing 2 μM cytochrome c. Oxygen consumption induced by 2 mM NADH was measured for 2 to 3 min followed by rotenone (2 μM) addition. The rate of rotenone-insensitive respiration was subtracted from the total rate of NADH-dependent respiration.
Fluorescence time-lapse imaging for Ca2+ and NADH
For simultaneous measurements of [Ca2+]m and [Ca2+]c, cells were loaded with 2 μM Rhod-2-AM (Molecular Probes) in the presence of 15 mM malate for 15 min at 37°C. To measure [Ca2+]c in RGCs, neurons were loaded with 1 μM Fura-FF-AM (Molecular Probes) for 10 min at 37°C. To visualize mitochondria, 2 nM MitoTracker Red was included. High-speed, live-cell imaging was performed in perfusion buffer containing 140 mM NaCl, 3.9 mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, 1.2 mM Na2SO4, 0.4 mM Na2HPO4, 5.6 mM D-glucose, and 20 mM HEPES, pH 7.4. Cells on coverslips were placed in a perfusion chamber on the stage of an Olympus IX81 inverted microscope. Fluorescence was excited by a DG-4 (Sutter Instruments, Novato, CA, USA) Xenon-arc illumination unit through 340/10 nm and 380/10 nm bandpass filters for Fura-FF, a 492/18 nm filter for FAM, a 525/30nm filter for Rhod2-AM, and a 572/25 nm filter for MitoTracker Red. Fluorescence was detected by an ultra-sensitive cooled CCD camera (Photometrics Cascade 512B; Roper Scientific, Vista, CA, USA) through emission filters: 510/40 nm for Fura-FF, 535/20 nm for FAM, 600/45nm for Rhod-2-AM, and 630/60nm for MitoTracker Red. Data acquisition was controlled by Metafluor 6.2 (Molecular Devices, Silicon Valley, CA, USA).
For selective assessment of [Ca2+]m, high-resolution images were taken (512 × 512 16-bit 0.26 μm/pixel; at 5 s intervals) and fluorescence originating from mitochondria was separated by high-pass filtering of fluorescent images, whereas [Ca2+]c was determined over the nucleus35 using Metafluor Analyst (Molecular Devices).
For RGCs, MitoTracker Red and FAM fluorescence was measured once at the start of the experiment (512 × 512 16-bit 0.8 μm/pixel). Length and presence of mitochondria in processes of RGCs were determined by high-pass filtering and segmentation of images using locally adaptive techniques in Image Analyst MKII. Finally, the skeletal length of mitochondria and processes were calculated for FAM-positive cells. Mitochondrial length is given as mean skeletal length. Mitochondrial presence is defined as total mitochondrial length per total neurite length (see Supplementary Figure 3B). During time-lapse experiments, Fura-FF signals were recorded at 2 × 2 binning (256 × 256; 16-bit; 1.6 μm/pixel; 5 s/ratio frame). Fura-FF (Kd=2.9 μM) ratios were calibrated to [Ca2+] by exposing each sample to zero and high (10 mM) [Ca2+] at the end of the experiment with a procedure previously described.30 The Ca2+ calibration and analysis of Ca2+ extrusion rates were performed in Mathematica 5.2 (Wolfram Research, Oxfordshire, England, UK).
NADH autofluorescence in HeLa cells was measured using 340/10 nm excitation and 465/30 nm emission filters. Images were taken at 256 × 256 pixels; 16-bit; 0.8 μm/pixel, at 10 s intervals. Decay slope and half-life of fluorescence transients in histamine-stimulated cells were determined by standard functions in Mathematica 5.2. The percentage of NAD(H) reduction was expressed from the NAD(P)H autofluorescence intensity before application of FCCP scaled between the intensities measured in the presence of FCCP (0%) and rotenone (100%).
Accession codes
Abbreviations
- DOA:
-
dominant optic atrophy
- DCD:
-
delayed Ca2+ deregulation
- Drp1:
-
dynamin-related protein 1
- [Ca2+]c:
-
cytoplasmic Ca2+ concentration
- [Ca2+]m:
-
mitochondrial Ca2+ concentration
- Δψm:
-
mitochondrial membrane potential
- FCCP:
-
carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone
- MPT:
-
mitochondrial permeability transition
- mtDNA:
-
mitochondrial DNA
- nDNA:
-
nuclear DNA
- OMM:
-
outer mitochondrial membrane
- RGC:
-
retinal ganglion cell
- siRNA:
-
small interfering RNA
- TPP+:
-
tetraphenylphosphonium
References
Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000; 26: 211–215.
Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000; 26: 207–210.
Lenaers G, Reynier P, Elachouri G, Soukkarieh C, Olichon A, Belenguer P et al. OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol 2009; 41: 1866–1874.
Ju WK, Misaka T, Kushnareva Y, Nakagomi S, Agarwal N, Kubo Y et al. OPA1 expression in the normal rat retina and optic nerve. J Comp Neurol 2005; 488: 1–10.
Pesch UE, Fries JE, Bette S, Kalbacher H, Wissinger B, Alexander C et al. OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina. Invest Ophthalmol Vis Sci 2004; 45: 4217–4225.
Aijaz S, Erskine L, Jeffery G, Bhattacharya SS, Votruba M . Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer. Invest Ophthalmol Vis Sci 2004; 45: 1667–1673.
Williams PA, Morgan JE, Votruba M . Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Brain 2010; 133: 2942–2951.
Yu-Wai-Man P, Griffiths PG, Chinnery PF . Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res 2011; 30: 81–114.
Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003; 278: 7743–7746.
Griparic L, van der Wel NN, Orozco IJ, Peters PJ, van der Bliek AM . Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem 2004; 279: 18792–18798.
Arnoult D, Grodet A, Lee YJ, Estaquier J, Blackstone C . Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J Biol Chem 2005; 280: 35742–35750.
Ban T, Heymann JA, Song Z, Hinshaw JE, Chan DC . OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation. Hum Mol Genet 2010; 19: 2113–2122.
Frey TG, Mannella CA . The internal structure of mitochondria. Trends Biochem Sci 2000; 25: 319–324.
Perkins G, Bossy-Wetzel E, Ellisman MH . New insights into mitochondrial structure during cell death. Exp Neurol 2009; 218: 183–192.
Zick M, Rabl R, Reichert AS . Cristae formation-linking ultrastructure and function of mitochondria. Biochim Biophys Acta 2009; 1793: 5–19.
Darshi M, Mendiola VL, Mackey MR, Murphy AN, Koller A, Perkins GA et al. ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function. J Biol Chem 2011; 286: 2918–2932.
Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006; 126: 177–189.
Yamaguchi R, Lartigue L, Perkins G, Scott RT, Dixit A, Kushnareva Y et al. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization. Mol Cell 2008; 31: 557–569.
Sun MG, Williams J, Munoz-Pinedo C, Perkins GA, Brown JM, Ellisman MH et al. Correlated three-dimensional light and electron microscopy reveals extensive transformation of the mitochondrial inner membrane during apoptosis. Nat Cell Biol 2007; 9: 1057–1065.
Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2002; 2: 55–67.
Yamaguchi R, Perkins G . Dynamics of mitochondrial structure during apoptosis and the enigma of Opa1. Biochim Biophys Acta 2009; 1787: 963–972.
Fulop L, Szanda G, Enyedi B, Varnai P, Spat A . The effect of OPA1 on mitochondrial Ca(2) signaling. PloS One 2011; 6: e25199.
Dayanithi G, Chen-Kuo-Chang M, Viero C, Hamel C, Muller A, Lenaers G . Characterization of Ca2+ signalling in postnatal mouse retinal ganglion cells: involvement of OPA1 in Ca2+ clearance. Ophthalmic Genet 2010; 31: 53–65.
Denton RM . Regulation of mitochondrial dehydrogenases by calcium ions. Biochim Biophys Acta 2009; 1787: 1309–1316.
Mattson MP . Calcium and neurodegeneration. Aging Cell. 2007; 6 337–350.
Manev H, Favaron M, Guidotti A, Costa E . Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death. Mol Pharmacol 1989; 36: 106–112.
Randall RD, Thayer SA . Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. J Neurosci 1992; 12: 1882–1895.
Budd SL, Nicholls DG . Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurochem 1996; 676: 2282–2291.
Abramov AY, Duchen MR . Impaired mitochondrial bioenergetics determines glutamate-induced delayed calcium deregulation in neurons. Biochim Biophys Acta 2010; 1800: 297–304.
Gerencser AA, Mark KA, Hubbard AE, Divakaruni AS, Mehrabian Z, Nicholls DG et al. Real-time visualization of cytoplasmic calpain activation and calcium deregulation in acute glutamate excitotoxicity. J Neurochem 2009; 110: 990–1004.
Ullian EM, Barkis WB, Chen S, Diamond JS, Barres BA . Invulnerability of retinal ganglion cells to NMDA excitotoxicity. Mol Cell Neurosci 2004; 26: 544–557.
Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ . Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 2004; 15: 5001–5011.
Chen H, Chomyn A, Chan DC . Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 2005; 280: 26185–26192.
Perkins GA, Renken CW, Frey TG, Ellisman MH . Membrane architecture of mitochondria in neurons of the central nervous system. J Neurosci Res 2001; 66: 857–865.
Gerencser AA, Adam-Vizi V . Selective, high-resolution fluorescence imaging of mitochondrial Ca2+ concentration. Cell Calcium 2001; 30: 311–321.
Barres BA, Silverstein BE, Corey DP, Chun LL . Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron 1988; 1: 791–803.
Kamei S, Chen-Kuo-Chang M, Cazevieille C, Lenaers G, Olichon A, Belenguer P et al. Expression of the Opa1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregation of the mitochondrial network. Invest Ophthalmol Vis Sci 2005; 46: 4288–4294.
Lodi R, Tonon C, Valentino ML, Iotti S, Clementi V, Malucelli E et al. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol 2004; 56: 719–723.
Zhang Z, Wakabayashi N, Wakabayashi J, Tamura Y, Song WJ, Sereda S et al. The dynamin-related GTPase Opa1 is required for glucose-stimulated ATP production in pancreatic beta cells. Mol Biol Cell 2011; 22: 2235–2245.
Amutha B, Gordon DM, Gu Y, Pain D . A novel role of Mgm1p, a dynamin-related GTPase, in ATP synthase assembly and cristae formation/maintenance. Biochem J. 2004; 381: 19–23.
Meeusen S, DeVay R, Block J, Cassidy-Stone A, Wayson S, McCaffery JM et al. Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1. Cell 2006; 127: 383–395.
Misaka T, Murate M, Fujimoto K, Kubo Y . The dynamin-related mouse mitochondrial GTPase OPA1 alters the structure of the mitochondrial inner membrane when exogenously introduced into COS-7 cells. Neurosci Res 2006; 55: 123–133.
Sesaki H, Southard SM, Yaffe MP, Jensen RE . Mgm1p, a dynamin-related GTPase, is essential for fusion of the mitochondrial outer membrane. Mol Biol Cell 2003; 14: 2342–2356.
Song Z, Ghochani M, McCaffery JM, Frey TG, Chan DC . Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell 2009; 20: 3525–3532.
Vogel F, Bornhovd C, Neupert W, Reichert AS . Dynamic subcompartmentalization of the mitochondrial inner membrane. J Cell Biol 2006; 175: 237–427.
Mannella CA . The relevance of mitochondrial membrane topology to mitochondrial function. Biochim Biophys Acta 2006; 1762: 140–147.
Sukhorukov VM, Bereiter-Hahn J . Anomalous diffusion induced by cristae geometry in the inner mitochondrial membrane. PloS One 2009; 4: e4604.
Van Bergen NJ, Crowston JG, Kearns LS, Staffieri SE, Hewitt AW, Cohn AC et al. Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy. PloS One 2011; 6: e21347.
Kong D, Xu L, Yu Y, Zhu W, Andrews DW, Yoon Y et al. Regulation of Ca2+-induced permeability transition by Bcl-2 is antagonized by Drpl and hFis1. Mol Cell Biochem 2005; 272: 187–199.
Nicholls DG . Mitochondrial calcium function and dysfunction in the central nervous system. Biochim Biophys Acta 2009; 1787: 1416–1424.
Ju WK, Kim KY, Angert M, Duong-Polk KX, Lindsey JD, Ellisman MH et al. Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci 2009; 50: 707–716.
Jahani-Asl A, Pilon-Larose K, Xu W, MacLaurin JG, Park DS, McBride HM et al. The mitochondrial inner membrane GTPase, optic atrophy 1 (Opa1), restores mitochondrial morphology and promotes neuronal survival following excitotoxicity. J Biol Chem 2011; 286: 4772–4782.
Castilho RF, Hansson O, Ward MW, Budd SL, Nicholls DG . Mitochondrial control of acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurosci 1998; 18: 10277–10286.
Yadava N, Nicholls DG . Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J Neurosci 2007; 27: 7310–7317.
Bossy-Wetzel E, Newmeyer DD, Green DR . Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998; 17: 37–49.
Lawrence A, Bouwer JC, Perkins G, Ellisman MH . Transform based backprojection for volume reconstruction of large format electron microscope tilt series. J Struct Biol 2006; 154: 144–167.
Wong A, Cortopassi G . Reproducible quantitative PCR of mitochondrial and nuclear DNA copy number using the LightCycler. Methods Mol Biol 2002; 197: 129–137.
Kushnareva YE, Wiley SE, Ward MW, Andreyev AY, Murphy AN . Excitotoxic injury to mitochondria isolated from cultured neurons. J Biol Chem 2005; 280: 28894–28902.
Gostimskaya IS, Grivennikova VG, Zharova TV, Bakeeva LE, Vinogradov AD . In situ assay of the intramitochondrial enzymes: use of alamethicin for permeabilization of mitochondria. Anal Biochem 2003; 313: 46–52.
Acknowledgements
We thank Dr. E Monosov for help in fluorescence imaging, Dr. B Barres and colleagues for teaching us to prepare RGC cultures, Dr. Y Kubo for OPA1 antibodies, Dr. A Andreyev for critical reading of the manuscript, and WD Lee for technical assistance. This work was supported by NIH Grants R01 NS047456, R01 NS047456, and R01 EY016164 (to EB-W), NIH Grant R01 EY018658 (to W-KJ), and NIH Grants P41RR004050 and R01 NS14718 (to MHE).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by JM Hardwick
Supplementary Information accompanies the paper on Cell Death and Differentiation website
Rights and permissions
About this article
Cite this article
Kushnareva, Y., Gerencser, A., Bossy, B. et al. Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity. Cell Death Differ 20, 353–365 (2013). https://doi.org/10.1038/cdd.2012.128
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cdd.2012.128
- Springer Nature Limited
Keywords
This article is cited by
-
Mitochondrial dynamics-related genes DRP1 and OPA1 contributes to early diagnosis of cognitive impairment in diabetes
BMC Geriatrics (2023)
-
The mitochondrial fusion protein OPA1 is dispensable in the liver and its absence induces mitohormesis to protect liver from drug-induced injury
Nature Communications (2023)
-
OPA1 drives macrophage metabolism and functional commitment via p65 signaling
Cell Death & Differentiation (2023)
-
Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types
Discover Mental Health (2023)
-
Crosstalk between adenine nucleotide transporter and mitochondrial swelling: experimental and computational approaches
Cell Biology and Toxicology (2023)